Unilateral subthalamotomy in the treatment of Parkinson's disease.

Full Abstract

Hyperactivity in the subthalamic nucleus (STN) is seen in animal models of Parkinson's disease, and lesioning of the STN dramatically relieves the animal's parkinsonism. Deep brain stimulation (DBS) of the STN is an effective treatment for patients with advanced Parkinson's disease. We have studied the effects of a unilateral lesion placed in the STN in predominantly hemi-parkinsonian patients. Twenty-one patients with advanced idiopathic Parkinson's disease were studied. Seventeen had asymmetrical tremor-dominant Parkinson's disease and four had bilateral disease. All patients underwent radiofrequency lesioning of the dorsolateral part of the STN under stereotactic guidance. The four patients with bilateral disease had, in addition, an electrode implanted contralaterally in the STN. Twenty-one patients have been followed for a minimum of 12 months. Clinical evaluation included the use of the Unified Parkinson's Disease Rating Scale (UPDRS) before and after surgery. Post-operative high-resolution MRI was performed in each patient to confirm lesion location, and this was correlated with clinical outcome. There was improvement in contralateral tremor, rigidity and bradykinesia in all patients followed for 6, 12 and 24 months, with the effect on tremor being greatest. L-dopa equivalent daily intake was approximately halved, and this resulted in a significant reduction in dyskinesia. Psychometric test scores were mostly unchanged or improved. All lesions were successfully located in the dorsolateral STN. Nineteen of the 21 lesions extended beyond the STN to involve pallidofugal fibres (H2 field of Forel) and the zona incerta (ZI). Lesion-induced dyskinesias were not a management problem except in one patient, whose lesion was confined to the STN. This patient was successfully treated with deep brain stimulator placement in the region of H2/ZI. Unilateral STN lesions can be made safely and are an effective alternative to thalamotomy, pallidotomy and unilateral STN DBS for the treatment of asymmetrical tremor-dominant advanced Parkinson's disease. Com bined lesioning of the dorsolateral STN and H2/ZI is particularly effective.

Learn Faster Today Improve your study skills

Author information

Author/s: Patel, Nikunj K (NK); Heywood, Peter (P); O'Sullivan, Karen (K); McCarter, Renée (R); Love, Seth (S); Gill, Steven S (SS);

Affiliation: Institute of Clinical Neurosciences, Frenchay Hospital, Bristol, UK.

Journal and publication information

Publication Type: Journal Article

Journal: Brain : a journal of neurology (Brain), published in England. (Language: eng)

Reference: 2003-May; vol 126 (issue Pt 5) : pp 1136-45

Dates: Created 2003/04/11; Completed 2003/07/18; Revised 2004/11/17;

PMID: 12690053, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Antiparkinson Agents - therapeutic use
Catheter Ablation
Female
Follow-Up Studies
Humans
Levodopa - therapeutic use
Male

Male
Neuropsychological Tests
Parkinson Disease - drug therapy; psychology; surgery
Postoperative Period
Statistics, Nonparametric
Subthalamic Nucleus - surgery
Treatment Outcome

Associated Chemicals: Antiparkinson Agents (0) ; Levodopa (0)

These are the highest related articles currently in the database:

See 100+ related articles.